Learn more

MASTERFARM S L

Overview
  • Total Patents
    13
About

MASTERFARM S L has a total of 13 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Spain, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets foods and drinks, pharmaceuticals and biotechnology are PETERSON SCOTT, LIU GUOCAN and EURORGA.

Patent filings in countries

World map showing MASTERFARM S Ls patent filings in countries

Patent filings per year

Chart showing MASTERFARM S Ls patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Espelleta Gil Gabriel 11
#2 Junca Riuro Miquel 11
#3 Junca Riuro Ferran 10
#4 Melendo Banos Jaime 8
#5 Junca Busquets Josep 8
#6 Agut Sanchez Julian 7
#7 Benavent Quilez Purificacion 6
#8 Fernandez Navarro Carlos 6
#9 Quijano Garcia Pilar 5
#10 Garcia Pilar Quijano 1

Latest patents

Publication Filing date Title
ES2319049A1 COMPOSITION THAT INCLUDES HYDROLYZED COLLAGEN AND HIALURONIC ACID FOR THE IMPROVEMENT OF CONSEQUENTIAL FUNCTIONAL DIFFICULTIES TO ALTERATIONS OF THE ARTICULAR CARTILAGOS.
ES2303468A1 "A PULVERULENT PHARMACEUTICAL COMPOSITION THAT INCLUDES IBUPROFEN".
ES2298071A1 HYDROLYZED ENZYMATIC COLLAGEN AND PROCEDURE OF OBTAINING.
ES2288791A1 PROCEDURE FOR OBTAINING A COLLAGEN HYDROLYZE. ENZYMATIC HYDROLYZE OF COLLAGEN OBTAINABLE BY THE PROCEDURE AND USES OF THE SAME.
ES2211334A1 NUTRITIONAL SUPPLEMENT FOR THE TREATMENT OF SYNDROMES RELATED TO FATIGUE.
WO9948516A1 Utilization of gelatine hydrolizats
ES2093557A1 Procedure for obtaining a highly concentrated solution of hydrolyzed gelatin free of odor and unpleasant taste.
ES2104507A1 Use of gelatin hydrolyzate to prepare a pharmaceutical composition intended for the prevention and treatment of hip dysplasia in dogs.
ES2087030A1 Use of gelatine hydrolyze as a co-adjuvant in treatments intended to offset calcium deficit.